We take pride in offering this cutting-edge treatment as part of our commitment to providing effective, minimally invasive solutions that work with your bodys natural processes rather than against them.
November 17, 2023
Orforglipron, an Oral GLP-1 Receptor Agonist for Obesity Treatment, New England Journal of Medicine, 2025
Reviews and safety studies have found only a few isolated reports of menstrual or reproductive changes, meaning that shifts in cycle length, bleeding, or PMS symptoms appear to be rare
Weight management indications (Wegovy, Zepbound) are another story
Dual GIP & GLP-1 agonist weekly injection GLP-1 receptor agonist weekly injection Daily injection proven appetite suppressant Daily injection affordable liraglutide alternative Capsule reduces fat absorption Every member is a qualified healthcare professional dedicated to your long-term success